Biotech | May 19, 2026
NunaBio secures £6.5 million to scale DNA manufacturing platform
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
Union health ministry secretary Punya Salila Srivastava lauds HLL’s six decades of contribution to public healthcare and social development
Deployment aims to improve serialization efficiency by 45% and enhance regulatory compliance across global export markets
The country’s strength lies not just in technology availability but in adoption behaviour
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
Despite the strong results, investigators cautioned that the study has limitations, including its open-label Phase II design, lack of randomization, and reliance on a historical external control arm
AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
Tecentriq SC reduces treatment administration time by nearly 80 percent and has the potential to lower indirect treatment costs
According to the analysis, just 23% of patients aged 18–29 were formally diagnosed with TD
Subscribe To Our Newsletter & Stay Updated
